137 related articles for article (PubMed ID: 33831675)
1. Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines.
Palakhachane S; Ketkaew Y; Chuaypen N; Sirirak J; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
Bioorg Chem; 2021 Jul; 112():104831. PubMed ID: 33831675
[TBL] [Abstract][Full Text] [Related]
2. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
4. The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.
Oekchuae S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631331
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Antitumor Activity of Triazole-Containing Sorafenib Analogs.
Ye W; Yao Q; Yu S; Gong P; Qin M
Molecules; 2017 Oct; 22(10):. PubMed ID: 29064424
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
8. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophore.
Wu MJ; Wu DM; Chen JB; Zhao JF; Gong L; Gong YX; Li Y; Yang XD; Zhang H
Bioorg Med Chem Lett; 2018 Aug; 28(14):2543-2549. PubMed ID: 29884535
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids.
Awasthi BP; Chaudhary P; Guragain D; Jee JG; Kim JA; Jeong BS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1884-1897. PubMed ID: 34340602
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
12. Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-Raf
Sun S; He Z; Huang M; Wang N; He Z; Kong X; Yao J
Bioorg Med Chem; 2018 May; 26(9):2381-2391. PubMed ID: 29631788
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
14. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
[TBL] [Abstract][Full Text] [Related]
20. Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.
Vojtičková M; Dobiaš J; Hanquet G; Addová G; Cetin-Atalay R; Yildirim DC; Boháč A
Eur J Med Chem; 2015 Oct; 103():105-22. PubMed ID: 26344911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
